FdaApplication
ANDA 213553
Identifiers
- fda_app_no: ANDA213553
Properties
| Property | Value |
|---|---|
| applicant_name | XIROMED PHARMA ESPANA SL |
| application_type | ANDA |
| approval_date | 2021-08-13 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FULVESTRANT | FULVESTRANT | 250MG/5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR |
1 product